SCHEMBL25074352

SCHEMBL25074352

CN1CCN(C(=O)CCC2CCN(C)C2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 3/20 0.54
GNAO1 P09471 3/20 0.54
GNAI1 P63096 3/20 0.54
ITGB3 P05106 1/20 0.50
ITGA2B P08514 1/20 0.50
F2R P25116 1/20 0.50
HSD11B1 P28845 1/20 0.50
ALDH1A1 P00352 3/20 0.49
ATM Q13315 2/20 0.49
TP53 P04637 1/20 0.49
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
TPSAB1 Q15661 1/20 0.41
TPSD1 Q9BZJ3 1/20 0.41
TPSG1 Q9NRR2 1/20 0.41
CACNA2D1 P54289 1/20 0.41
CACNA1B Q00975 1/20 0.41
CACNB1 Q02641 1/20 0.41
CACNA1C Q13936 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25074008 1.00 GNAI3 (0.54) GNAI3GNAO1GNAI1ITGB3ITGA2B
SCHEMBL25074011 1.00 GNAI3 (0.54) GNAI3GNAO1GNAI1ITGB3ITGA2B
SCHEMBL4420752 0.84 GNAI3 (0.59) GNAI3GNAO1GNAI1ITGB3ITGA2B
SCHEMBL26042822 0.83 KMT2A (0.51) GNAI3GNAO1GNAI1ITGB3ITGA2B
SCHEMBL23603458 0.82 GNAI3 (0.45) GNAI3GNAO1GNAI1ALDH1A1HTT
SCHEMBL25955527 0.82 KMT2A (0.57) GNAI3GNAO1GNAI1ITGB3ITGA2B
SCHEMBL13812318 0.80 GNAI3 (0.55) GNAI3GNAO1GNAI1ITGB3ITGA2B
SCHEMBL15171759 0.78 GNAI3 (0.41) GNAI3GNAO1GNAI1ITGB3ITGA2B
SCHEMBL12049756 0.78 NAMPT (0.50) GNAI3GNAO1GNAI1HTTTPSAB1
SCHEMBL27314179 0.78 GNAI3 (0.42) GNAI3GNAO1GNAI1ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023255-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF NURIX THERAPEUTICS, INC. (US) 2023-02-23 WO disclosed